Superworth

Rezolute EPS RZLT

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.76
Latest quarter, Q4 FY26
−$0.20
Fiscal year 2026
−$0.76

Rezolute's earnings per share was −$0.76 over the twelve months to Jun 30, 2026.

In its latest quarter, Q4 FY26, it was −$0.20.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2026−$0.76n/a
FY2025−$0.97n/a
FY2024−$1.33n/a
FY2023−$1.00n/a
FY2022−$2.67n/a
FY2021−$2.72n/a
FY2020−$3.55n/a
FY2019−$25.00n/a
FY2018−$26.50n/a
FY2017−$28.50n/a
FY2016−$42.00n/a
FY2015−$27.50n/a
FY2014−$63.00n/a
FY2013−$55.00n/a
FY2012−$6.60n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q4 FY26−$0.20n/a−$0.76
Q3 FY26−$0.16n/a−$0.82
Q2 FY26−$0.22n/a−$0.93
Q1 FY26−$0.18n/a−$0.93
Q4 FY25−$0.26n/a−$0.97
Q3 FY25−$0.27n/a−$1.15
Q2 FY25−$0.22n/a−$1.22
Q1 FY25−$0.22n/a−$1.27
Q4 FY24−$0.44n/a−$1.33
Q3 FY24−$0.34n/a−$1.14
Q2 FY24−$0.27n/a−$1.10
Q1 FY24−$0.28n/a−$1.09

Against its peers

Companies in Drug Manufacturers - General nearest Rezolute's size, closest first, today.

CompanyEPS, 12 monthsGrowth
RZLTRezolute−$0.76
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
NATRNatures Sunshine Products$1.01+36% a year
COLLCollegium Pharmaceutical$1.24+19% a year
ABUSArbutus Biopharma$0.78
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
Peer median$0.97

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Rezolute

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.